Co-Founder, SVP, Hearing Biology and Translational Research at Frequency Therapeutics - Woburn, MA, US
Frequency Therapeutics is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Our lead product candidate, FX-322, is designed to regenerate auditory hair cells to restore hearing for the most common form of hearing loss.